Cytokines in human breast cancer: IL-1α and IL-1β expression

Oncology Reports

Volumn 6, Issue 1, 1999, Pages 65-70

  Kurtzman, Scott H ^a,c   Anderson, Kathleen H ^a   Wang, Yanping ^a   Miller, Lauri J ^b   Renna, Maria ^b   Stankus, Marra ^a   Lindquist, Richard R ^b   Barrows, George ^b   Kreutzer, Donald L ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cytokines; Immunoassays; Interieukin 1

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 8; ISOPROTEIN; TUMOR PROTEIN;

ARTICLE; BREAST DISEASE; BREAST TUMOR; CANCER INVASION; CARCINOMA IN SITU; CHEMISTRY; FEMALE; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PAGET NIPPLE DISEASE; PATHOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION;

BREAST DISEASES; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN ISOFORMS;

EID: 0032621720     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Folkman D: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
2. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma (see comments). J Natl Cancer Inst 84: 1875-1887, 1992.
3. Lewis CE, Leek R, Harris A and McGee JO: Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages (Review). J Leukoc Biol 57: 747-751, 1995.
4. Strieter RM, Polverini PJ, Arenber DA, Walz A, Opdenakker G, van Damme J and Kunkel SL: Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol 57: 752-762, 1995.
5. Leek RD, Harris AL and Lewis CE: Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukoc Biol 56: 423-435, 1994.
6. Hu DE, Hori Y and Fan TP: Interleukin-8 stimulates angiogenesis in rats. Inflammation 17: 135-143, 1993.
7. Roesel JF and Nanney LB: Assessment of differential cytokine effects on angiogenesis using an in vivo model of cutaneous wound repair. J Surg Res 58: 449-459, 1995.
8. Sica A, Matsushima K, van Damme J, Wang J, Polentanitte M, Dejana N, Collotta E and Mantovani A: IL-1 transcription activates the NCF/IL8 gene in endothelial cells. Immunology 69: 548-553, 1990.
9. Kurtzman SH, Miller L, Anderson K, Wang Y and Kreutzer DL: Cytokine regulation of angiogenesis factor expression in human breast cancer. Society of Surgical Oncology, Atlanta, GA, 1996.
10. Cohen RF, Contrino J, Spiro JD, Mann EA, Chen LL and Kreutzer DL: Interleukin-8 expression by head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 121:202-209, 1995.
11. Dvorak H: Tumors: wounds that do not heal. N Engl J Med 315: 1650-1659, 1986.
12. Brennan FM, Zachariae CO, Chantry D, Larsen CG, Turner M, Maini RN, Matsushima K and Feldmann M: Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur J Immunol 20: 2141-2144, 1990.
13. Endo H, Akahoshi T, Takagishi K, Kashiwazaki S and Matsushima K: Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res 10: 245-252, 1991.
14. Elford PR and Cooper PH: Induction of neutrophil-mediated cartilage degradation by interleukin-8. Arthritis Rheum 4: 325-332, 1991.
15. Koch AE, Kunkel SL, Burrows JC, Evanoff HL, Haines GK, Pope RM and Strieter RM: Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 147: 2187-2195, 1991.
16. Lindley IL Ceska M and Peichl P: NAP-1/IL-8 in rheumatoid arthritis. Adv Exp Med Biol 305: 147-156, 1991.
17. Peichl P, Ceska M, Effenberger F, Haberhauer G, Broell H and Lindley IJ: Presence of NAP-l/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis. Scand J Immunol 34: 333-339, 1991.
18. Hyams JS, Fitzgerald JE, Wyzga N, Muller R, Treem WR, Justmich CJ and Kreutzer DL: Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease? J Pediatr Gastroenterol Nutr 21: 419-425, 1995.
19. Radema SA, Tytgat GN and van Deventer SJ: In situ detection of interleukin-1 beta and interleukin 8 in biopsy specimens from patients with ulcerative colitis. Adv Exp Med Biol 371B: 1297-1299, 1995.
20. Kline JN, Schwartz DA, Monick MM, Floerchinger CS and Hunninghake GW: Relative release of interleukin-1 beta and interlcukin-1 receptor by alveolar macrophages. Chest 104: 47-53, 1993.
21. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627-1652, 1991.
22. Dinarello CA: Biologic basis for interleukin-1 in disease (Review). Blood 87: 2095-2147, 1996.
23. Mann EA, Spiro JD, Chen LL and Kreutzer DL: Cytokine expression by head and neck squamous cell carcinomas. Am J Surg 164: 567-573, 1992.
24. Basso D, Piebani M, Fogar P, Panozzo MP, Meggiato T, De Paoli M and Del Favero G: Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes. Int J Clin Lab Res 25: 40-43, 1995.
25. Alexandroff AB, Jackson AM, Esuvaranathan K, Prescott S and James K: Autocrine regulation of ICAM-1 expression on bladder cancer cell lines: evidence for the role of IL-1 alpha. Immunol Lett 40: 117-124, 1994.
26. Koch I, Depenbrock H, Danhauser-Riedl S, Rastetter JW and Hanauske AR: Interleukin 1 modulates growth of human renal carcinoma cells in vitro. Br J Cancer 71: 794-800, 1995.
27. Hsieh TC and Chiao JW: Growth modulation of human prostatic cancer cells by interleukin-1 and interleukin-1 receptor antagonist. Cancer Lett 95: 119-123, 1995.
28. Raitano AB and Korc M: Growth inhibition of a human colorectal carcinoma cell line fay interleukin 1 is associated with enhanced expression of gamma-interferon receptors. Cancer Res 53: 636-640, 1993.
29. Woodworth CD, McMullin E, Iglesias M and Plowman CD: Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc Natl Acad Sci USA 92: 2840-2844, 1995.
30. Kayser L, Broholm H, Francis D, Perrild H, Olsen BE, Bendtzen K and Hoyer PE: Immunocytochemical localisation of interleukin-1 alpha and mterleukin-6 in thyroid tissues from patients with neoplastic or autoimmune thyroid disorders. Autoimmunity 20: 75-82, 1995.
31. Yoshimi N, Sato S, Makita H, Wang A, Hirose Y, Tanaka T and Mori H: Expression of cytokines, TNF-alpha and IL-1 alpha, in MAM acetate and 1-hydroxyanthraquinone-induced colon carcinogenesis of rats. Carcinogenesis 15: 783-785, 1994.
32. Schrey MP and Patel KV: Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators. Br J Cancer 72: 1412-1419, 1995.
33. Costantino A, Vinci C, Mineo R, Frasca F, Pandini G, Milazzo G, Vigneri R and Belfiore A: Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity. Endocrinology 137:4100-4107, 1996.
34. Danforth DN Jr and Sgagias MK: Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res 53: 1538-1545, 1993.
35. Speiser P, Zeillinger R, Wiltschke C, Sedlak J and Chorvath B: IL-1 alpha induced, TNF alpha mediated HLA class II (DR) antigen up-regulation in a human ductal breast carcinoma cell line ZR-75-1. Neoplasma 40: 137-140, 1993.